Home / Pharmaceuticals / Cryptococcosis Market By Treatment (Amphotericin B, Flucytosine, Fluconazole) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Cryptococcosis Market By Treatment (Amphotericin B, Flucytosine, Fluconazole) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Published: May 2017 | Report Code: 58453-05-17

Cryptococcosis is a potentially fatal fungal disease occurs due to Cryptococcus. Factors such, increase in prevalence of fatal fungal disease, rising treatment awareness and last-stage HIV patients developing the disease are driving the growth of Cryptococcosis market worldwide.

The report titled “Cryptococcosis Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall Cryptococcosis market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on treatment type (Amphotericin B, Flucytosine, Fluconazole and Others treatment options) and different geographical regions.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global Cryptococcosis market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global Cryptococcosis market is studied for the following regional markets:   

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global Cryptococcosis market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global Cryptococcosis market. This report concludes with company profiles section that highlights major information about the key players engaged in global Cryptococcosis market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global Cryptococcosis market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Cryptococcosis Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Cryptococcosis Market Snapshot
2.2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
2.3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)

Chapter 3 Cryptococcosis Market Analysis
3.1 Global Cryptococcosis Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Significant Unmet Need
3.2.1.2 High prevalence of Cryptococcosis and other fungal diseases
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance in some countries
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Cryptococcosis Market

Chapter 4 Global Cryptococcosis Market, by Treatment Type
4.1 Overview
4.2 Amphotericin B
4.3 Flucytosine
4.4 Fluconazole
4.5 Other (Voriconazole, surgery treatment, etc.)

Chapter 5 Global Cryptococcosis Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alkopharma Inc.
6.3 Astellas Pharma Inc.
6.4 Bristol-Myers Squibb Company
6.5 Glenmark Pharmaceuticals
6.6 Janssen Biotech, Inc. (a Johnson & Johnson)
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Sigmapharm Laboratories LLC.
6.10 Valeant Pharmaceuticals, Inc.

List Of Tables :

TABLE 1 Market Positioning of Key Players in Global Cryptococcosis Market
TABLE 2 Global Cryptococcosis Market, by Treatment Type, 2015 – 2025 (US$ Bn)
TABLE 3 Global Cryptococcosis Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 4 North America Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 5 Europe Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 6 Asia Pacific Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 Alkopharma INC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Astellas Pharma INC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 Glenmark Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Janssen Biotech, Inc. (a Johnson & Johnson): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Sigmapharm Laboratories LLC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Valeant Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

List Of Figures :

FIG. 1 Cryptococcosis Market: Research Methodology
FIG. 2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
FIG. 3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Cryptococcosis Market, by Geography, 2016
FIG. 1 Global Amphotericin B Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Flucytosine Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Fluconazole Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Other (Voriconazole, surgery treatment) Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 2 Latin America Cryptococcosis Market, 2015 – 2025 (US$ Bn)
FIG. 3 Middle East and Africa Cryptococcosis Market, 2015 – 2025 (US$ Bn)

Based on treatment type, the global cryptococcosis market is segmented as follows:  

  • Amphotericin B
  • Fluconazole
  • Flucytosine
  • Others (Voriconazole, surgery treatment, etc.)

Cryptococcosis is disease occurs due to a species of the fungus. Factors such as increasing prevalence of fatal fungal disease, advances in treatment options and HIV infected patients are at higher risk of fungal disease development are driving the growth of cryptococcosis market worldwide. Cryptococcus neoformans is the main cause of disease, it is rare among healthy individuals; however, it is a major cause of illness in HIV infected patients. According to Centers for Disease Control and Prevention (CDC), 1 million cases of cryptococcal meningitis occurs among HIV infected patients worldwide each year. Cryptococcosis treatment is generally consist of three phases such as induction, consolidation and maintenance. It is observed that Amphotericin B and Flucytosine is the most commonly used treatment regimens in market during induction therapy. Fluconazole and Itraconazole is treatment regimen given for at least 8 weeks after successful completion of 2 weeks induction therapy. It is observed that; Fluconazole is preferred regimen during maintenance therapy for at least 1 year. In the base year 2016, Flucytosine is major revenue contributing segment in global cryptococcosis market, due to the factors such as Flucytosine is responsible for reducing fungal burden in brain, spleen, and lungs also it is given as first line treatment in cryptococcosis infection.

Cryptococcosis Market

For the purpose of this study, the global cryptococcosis market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

The major causes of cryptococcosis are infection by C. neoformans and C. gattii. It is observed that approximately 5 to 8% of HIV-infected patients in developed countries diagnose with cryptococcosis. According to Centers for Disease Control and Prevention (CDC), every year approximately 1 million cases of cryptococcal meningitis occur among patient infected with HIV. In the base year 2016, North America was dominating Cryptococcosis market in terms of revenue due to the factors such as higher cost of drug, upsurge in funding by government agencies and private organizations in healthcare system, increase in incidence of the fungal infections in endemic areas of North America and higher investments in research and development are driving the market growth in North America. Europe is the second largest revenue generating region for Cryptococcosis market because technological advances, developed healthcare infrastructure and higher cost of medication are influencing the market growth of Cryptococcosis in Europe. It is observed that Middle East and Africa will show significant market growth during forecast period because the count of HIV infected patients is extremely high and increase in demand for cryptococcosis medication would drive the market growth during forecast period. However, factor such as comparatively lower cost of treatment medication may hinder the market growth of Cryptococcosis market in Middle East and Africa.

Cryptococcosis Market

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients